Literature DB >> 20357800

The anticonvulsants market.

Charlotte Mackey1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20357800     DOI： 10.1038/nrd3076

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.

Authors:  Roy G Beran; Samuel F Berkovic; Andrew B Black; Gytis Danta; Reinhard Hiersemenzel; Graham J Schapel; Frank J E Vajda
Journal:  Epilepsy Res       Date:  2005-01-06       Impact factor: 3.045

2.  Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.

Authors:  J J Cereghino; V Biton; B Abou-Khalil; F Dreifuss; L J Gauer; I Leppik
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

3.  [A descriptive study of migraine in a rural population of Area del Comtat].

Authors:  R Sánchez-Pérez; M Asensio; A Melchor; I Montiel; R Falip; J M Moltó; J Matías-Guiu
Journal:  Rev Neurol       Date:  1999 Feb 16-28       Impact factor: 0.870

4.  The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.

Authors:  M J Morrell; I Leppik; J French; J Ferrendelli; J Han; L Magnus
Journal:  Epilepsy Res       Date:  2003-05       Impact factor: 3.045

5.  Population-based door-to-door survey of migraine in Japan: the Daisen study.

Authors:  Takao Takeshima; Kumiko Ishizaki; Yoko Fukuhara; Tamami Ijiri; Masayoshi Kusumi; Yosuke Wakutani; Masatada Mori; Mika Kawashima; Hisanori Kowa; Yoshiki Adachi; Katsuya Urakami; Kenji Nakashima
Journal:  Headache       Date:  2004-01       Impact factor: 5.887

6.  Topiramate in migraine prevention: results of a large controlled trial.

Authors:  Stephen D Silberstein; Walter Neto; Jennifer Schmitt; David Jacobs
Journal:  Arch Neurol       Date:  2004-04
  6 in total
  3 in total

1.  Ambiguous bromine.

Authors:  Matt Rattley
Journal:  Nat Chem       Date:  2012-05-22       Impact factor: 24.427

2.  Valproic Acid Exposure during Early Postnatal Gliogenesis Leads to Autistic-like Behaviors in Rats.

Authors:  Tamanna Jahan Mony; Jae Won Lee; Cheryl Dreyfus; Emanuel DiCicco-Bloom; Hee Jae Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-11-30       Impact factor: 2.582

3.  Trends in the utilization of psychotropic medications in China from 2018 to 2021.

Authors:  Xinyan Zhang; Xiaowen Hu; Yuxuan Zhao; Christine Y Lu; Xiaoyan Nie; Luwen Shi
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.